The immune‐related adverse events paradox in locally advanced or metastatic urothelial cancer after atezolizumab immunotherapy : analysis of individual patient data from IMvigor210 and IMvigor211 trials

enthalten in: BJU International | 2024

von Robesti, D. | Nocera, L. | Belladelli, F. | +8

Definitive radiotherapy for extracranial oligoprogressive metastatic renal cell carcinoma as a strategy to defer systemic therapy escalation

enthalten in: BJU International | 2022

von De, B. | Venkatesan, A. | Msaouel, P. | +15

Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma : a comparison of outcomes

enthalten in: BJU International | 2021

von Esagian, S. | Khaki, A. | Diamantopoulos, L. | +43